These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 836076)

  • 1. Results of reflex photometric determinations of vasoconstriction after topical steroid application. Tachyphylaxis, relative and absolute refractory phase after single and multiple application of steroid.
    Altmeyer P; Cremer C
    Arch Dermatol Res (1975); 1977 Jan; 257(3):281-5. PubMed ID: 836076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. V. Vasoconstriction phaenomenon and tachyphylaxis after repeated steroid application (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):51-6. PubMed ID: 1259466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. IV. Time slope of vasoconstriction and reactive vasodilatation (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):43-50. PubMed ID: 1259465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. III. Vasoeffect of mineralocorticoids time slope of vasoconstriction influence of steroid concentration].
    Altmeyer P; Zaun H
    Arch Dermatol Forsch; 1974; 250(4):381-8. PubMed ID: 4447379
    [No Abstract]   [Full Text] [Related]  

  • 6. Tachyphylaxis to topical steroid measured by histamine-induced wheal suppression.
    Singh G; Singh PK
    Int J Dermatol; 1986 Jun; 25(5):324-6. PubMed ID: 3721670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The cutaneous vasoconstriction test in man as a means of evaluating topical corticoids. II. Cutaneous vasoconstrictive effects of topical corticoids in tests devised by various investigators (author's transl)].
    Lutz U; Weirich EG
    Dermatologica; 1974; 148(3):160-74. PubMed ID: 4836957
    [No Abstract]   [Full Text] [Related]  

  • 8. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.
    Singh S; Gupta A; Pandey SS; Singh G
    Dermatology; 1996; 193(2):121-3. PubMed ID: 8884147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoconstrictor activities and bio-availabilities of seven proprietary corticosteroid creams assessed using a non-occluded multiple dosage regimen; clinical implications.
    Barry BW; Woodford R
    Br J Dermatol; 1977 Nov; 97(5):555-60. PubMed ID: 588468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
    Singh SK; Nasir F
    Indian J Dermatol Venereol Leprol; 2015; 81(4):370-5. PubMed ID: 26144851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of mixtures of topical corticosteroids as a mechanism for improving total drug bioavailability: a preliminary report.
    Poulsen BJ; Chowhan ZT; Pritchard R; Katz M
    Curr Probl Dermatol; 1978; 7():107-20. PubMed ID: 752447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-frequency ultrasound sonophoresis to increase the efficiency of topical steroids: a pilot randomized study of humans.
    Maruani A; Boucaud A; Perrodeau E; Gendre D; Giraudeau B; Machet L
    Int J Pharm; 2010 Aug; 395(1-2):84-90. PubMed ID: 20472045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical steroid therapy in skin disease. A panel discussion.
    S Afr Med J; 1974 Aug; 48(42):suppl:1-8. PubMed ID: 4278512
    [No Abstract]   [Full Text] [Related]  

  • 14. Current dangers and problems in the topical use of steroids.
    Deakin MJ
    Med J Aust; 1976 Jan; 1(5):120-1. PubMed ID: 772378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical glucocorticoid augments IgE-mediated passive cutaneous anaphylaxis in Balb/C mice and mast cell deficient WBB6F1 v/v mice.
    Katayama I; Igawa K; Minatohara K; Nishioka K
    Clin Exp Allergy; 1997 Dec; 27(12):1477-83. PubMed ID: 9433944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM; Jurgovsky E
    Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible dosage regimens for topical steroids, assessed by vasoconstrictor assays using multiple applications.
    Woodford R; Haigh JM; Barry BW
    Dermatologica; 1983; 166(3):136-40. PubMed ID: 6852325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
    Poulsen BJ; Burdick K; Bessler S
    Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
    [No Abstract]   [Full Text] [Related]  

  • 19. Various vagaries of vasoconstriction.
    Burdick KH
    Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydrocortisone (cortisol) concentration and penetration gradient.
    Kranz G; Schaefer H; Zesch A
    Acta Derm Venereol; 1977; 57(3):269-73. PubMed ID: 71836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.